Xingkai An

509 total citations
19 papers, 351 citations indexed

About

Xingkai An is a scholar working on Psychiatry and Mental health, Neurology and Neurology. According to data from OpenAlex, Xingkai An has authored 19 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 9 papers in Neurology and 9 papers in Neurology. Recurrent topics in Xingkai An's work include Migraine and Headache Studies (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurological diseases and metabolism (5 papers). Xingkai An is often cited by papers focused on Migraine and Headache Studies (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurological diseases and metabolism (5 papers). Xingkai An collaborates with scholars based in China, Switzerland and Singapore. Xingkai An's co-authors include Qilin Ma, Qing Lin, Rong Peng, Jean‐Marc Burgunder, Jie Fang, Tao Li, Xiaorong Zhang, Yih‐Ru Wu, Jean‐Marc Burgunder and Yanming Xu and has published in prestigious journals such as Neurobiology of Aging, Movement Disorders and BMJ Open.

In The Last Decade

Xingkai An

18 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingkai An China 12 188 100 94 94 87 19 351
Caroline Ran Sweden 15 98 0.5× 175 1.8× 62 0.7× 268 2.9× 88 1.0× 35 490
Anne‐Marie Wills United States 12 444 2.4× 82 0.8× 65 0.7× 55 0.6× 81 0.9× 17 562
Juliane Schelle Germany 8 163 0.9× 326 3.3× 142 1.5× 91 1.0× 223 2.6× 8 568
Suzanne Granhøj Lindquist Denmark 10 136 0.7× 157 1.6× 56 0.6× 42 0.4× 140 1.6× 16 335
Eka Lepsveridze Georgia 12 72 0.4× 58 0.6× 38 0.4× 64 0.7× 156 1.8× 15 417
Eleonora Bazzini Italy 10 319 1.7× 87 0.9× 103 1.1× 17 0.2× 125 1.4× 11 562
Tony Jer‐Fu Lee United States 12 65 0.3× 155 1.6× 41 0.4× 74 0.8× 176 2.0× 23 448
Barbara Jasińska‐Myga Poland 15 540 2.9× 182 1.8× 124 1.3× 41 0.4× 138 1.6× 29 710
Irene Carunchio Italy 11 259 1.4× 86 0.9× 32 0.3× 115 1.2× 174 2.0× 13 564

Countries citing papers authored by Xingkai An

Since Specialization
Citations

This map shows the geographic impact of Xingkai An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingkai An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingkai An more than expected).

Fields of papers citing papers by Xingkai An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingkai An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingkai An. The network helps show where Xingkai An may publish in the future.

Co-authorship network of co-authors of Xingkai An

This figure shows the co-authorship network connecting the top 25 collaborators of Xingkai An. A scholar is included among the top collaborators of Xingkai An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingkai An. Xingkai An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yuan, Xiaodong, et al.. (2025). Association of the insulin resistance marker triglyceride glucose index with migraine: results of a cross-sectional and prospective cohort study. Journal of Oral & Facial Pain and Headache. 39(1). 165–175. 2 indexed citations
2.
Zhang, Mengyuan, Jie Fang, J. Tang, et al.. (2025). Exploring the Role of B-Cell Biotherapy in Myasthenia Gravis from a Genetic Perspective: A Mendelian Randomization Study. Molecular Neurobiology. 63(1). 115–115.
3.
An, Xingkai, Shanshan Zhao, Jie Fang, et al.. (2024). Identification of genetic susceptibility for Chinese migraine with depression using machine learning. Frontiers in Neurology. 15. 1418529–1418529. 2 indexed citations
4.
Fang, Jie, et al.. (2024). Associations of type 2 diabetes and the risk of migraine in Chinese populations. Diabetes & Metabolism. 50(2). 101518–101518. 6 indexed citations
5.
Fang, Jie, Xiaodong Yuan, Lu Yu, et al.. (2023). Serum neurofilament light chain levels in migraine patients: a monocentric case–control study in China. The Journal of Headache and Pain. 24(1). 149–149. 3 indexed citations
6.
Fang, Jie, Xiaodong Yuan, Xingkai An, et al.. (2018). Involvement of the Tetraspanin 2 (TSPAN2) Gene in Migraine: A Case-Control Study in Han Chinese. Frontiers in Neurology. 9. 714–714. 6 indexed citations
7.
An, Xingkai, et al.. (2017). Multilocus analysis reveals three candidate genes for Chinese migraine susceptibility. Clinical Genetics. 92(2). 143–149. 17 indexed citations
8.
Li, Zhiming, Li Zhong, Long Gu, et al.. (2016). Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese population. BMJ Open. 6(1). e009499–e009499. 12 indexed citations
9.
An, Xingkai, et al.. (2016). New evidence for involvement of ESR1 gene in susceptibility to Chinese migraine. Journal of Neurology. 264(1). 81–87. 16 indexed citations
10.
Fang, Jie, et al.. (2016). Analysis ofLRRK2,SNCA,andITGA8Gene Variants with Sporadic Parkinson’s Disease Susceptibility in Chinese Han Population. Parkinson s Disease. 2016. 1–6. 6 indexed citations
11.
Fang, Jie, et al.. (2015). Case-control study of GRIA1 and GRIA3 gene variants in migraine. The Journal of Headache and Pain. 17(1). 2–2. 18 indexed citations
12.
Ma, Qilin, Xingkai An, Zhiming Li, et al.. (2013). P268S in NOD2 associates with susceptibility to Parkinson’s disease in Chinese population. Behavioral and Brain Functions. 9(1). 19–19. 26 indexed citations
13.
An, Xingkai, et al.. (2013). Association of MTHFR C677T Polymorphism with Susceptibility to Migraine in the Chinese population. Neuroscience Letters. 549. 78–81. 23 indexed citations
14.
An, Xingkai, et al.. (2013). PRDM 16 rs2651899 Variant Is a Risk Factor for C hinese Common Migraine Patients. Headache The Journal of Head and Face Pain. 53(10). 1595–1601. 35 indexed citations
15.
Burgunder, Jean‐Marc, et al.. (2009). Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neuroscience Letters. 469(2). 256–259. 48 indexed citations
16.
Tan, Eng‐King, Chin-Song Lu, Rong Peng, et al.. (2009). Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese. Neurobiology of Aging. 31(12). 2194–2196. 14 indexed citations
17.
Zhang, Zijuan, Jean‐Marc Burgunder, Xingkai An, et al.. (2009). LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han‐Chinese from mainland China. Movement Disorders. 24(13). 1902–1905. 34 indexed citations
18.
Burgunder, Jean‐Marc, Xingkai An, Ying Wu, et al.. (2008). Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population. Neuroscience Letters. 442(3). 200–202. 21 indexed citations
19.
An, Xingkai, Rong Peng, Tao Li, et al.. (2008). LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han‐Chinese from mainland China. European Journal of Neurology. 15(3). 301–305. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026